Condition
Hematologic Cancer clinical trials and research
As of November 12, 2026, Find a Trial lists 13 Hematologic Cancer clinical trials that are recruiting, at sites in 6 countries (most in United States (6), Spain (2), France (2)). 1 was first registered in the last 30 days. By phase: Early Phase 1 (1). There are also 3 NIH-funded research projects on Hematologic Cancer, with $526,179 in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 13Clinical trials
- 3NIH research projects
- 1New in 30 days
- 6Countries
Newest Hematologic Cancer clinical trials
All recruiting trials (13)
-
Virtual reality to improve comfort for adults with hematologic cancer in hospital
Researchers are testing whether short VR experiences can help comfort and mood for adults with blood cancers who are staying in the hospital for at least 15 days.
-
Genetics of Blood Cancers in the U.S. population
This study tests how genetic factors relate to blood cancers by collecting saliva DNA and online health surveys from at least 10,000 U.S. adults.
-
Venetoclax added to reduced-intensity conditioning for combined stem cell and kidney transplant
This trial tests whether adding venetoclax to a reduced-intensity conditioning regimen is safe for adults with blood cancers who are receiving a combined stem cell and kidney transplant from a matched or partially matched donor.
-
Using exercise and nutrition to reduce CAR‑T neurotoxicity in adults with blood cancers
This test will try whether a structured exercise program alone or combined with nutrition advice can lower the risk or severity of neurotoxicity after CAR‑T therapy in adults (18–80) with hematologic cancer.
-
Florida ASCENT Program
This project will test whether combining the MyCarePulse EHR platform with ASCENT patient navigators helps adults with recent cancer diagnoses in Florida improve food security, diet quality, and confidence in healthy eating compared with standard care.
-
18F-G1 PET/CT to see early immunotherapy response in solid tumors and blood cancers
We are testing if the 18F-G1 PET/CT scan can help tell early on whether people with solid tumors or blood cancers will respond to immunotherapy.
-
Monitoring complications during immunotherapy for blood cancers
This study is testing a new way to keep an eye on patients with blood cancers during immunotherapy to catch problems early and improve their safety and care.
-
Using hypnosis to help manage anxiety in hematologic cancer patients
This study tests whether hypnosis can help adults with certain blood cancers feel less anxious about their diagnosis and treatment.
-
Assessing the effects of stopping maintenance therapy in multiple myeloma patients
This study is testing whether stopping maintenance therapy helps people with multiple myeloma who have had no signs of the disease for a while, by comparing their health to those who keep taking the treatment.
-
Exploring immune responses to cell therapy in tumors
This study is testing how the immune system reacts to a new cell therapy in patients with different types of tumors to see if these reactions can help predict how well the treatment works and what side effects might occur.
-
Improving access to cancer trials for underrepresented minorities
This study is trying out a new program to help people from underrepresented backgrounds with advanced cancers learn about and access genomic testing for clinical trials.
-
Improving care for cancer survivors with chronic conditions
This study is testing a new care approach to see if it can help cancer survivors with other health issues get better support and improve their overall health.
-
Understanding cancer through genomic profiling and analytics
This study is trying to understand the genetic features of different types of cancer in people from a community healthcare system to improve screening and treatment options.
NIH-funded research (3)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Mindfulness for Sleep and Symptom Relief in Hematologic Cancer Patients During Hospital Stay
A physician-led mindfulness program delivered via a mobile app during hospitalization aims to improve sleep and reduce fatigue, distress, and pain for patients with blood cancers receiving high-dose chemotherapy.
-
Mindfulness for Better Sleep and Comfort in Cancer Patients
This project offers a mindfulness program to help patients with blood cancers sleep better and feel more comfortable during and after their hospital stays for chemotherapy.
-
Mindfulness techniques to help hematologic cancer patients manage sleep issues during and after hospital treatment
This study is testing a friendly online program called Nite2Day+ to help patients with blood cancers who have trouble sleeping while in the hospital, teaching them relaxation techniques to improve their sleep and feel better overall.
Related topics
Quick answers
How many Hematologic Cancer clinical trials are recruiting right now?
13, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 6 countries. The most sites are in United States (6 trials), Spain (2 trials), France (2 trials), Ireland (1 trial), China (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.